ATE553103T1 - Verfahren zur herstellung von (s)-pantoprazol - Google Patents

Verfahren zur herstellung von (s)-pantoprazol

Info

Publication number
ATE553103T1
ATE553103T1 AT03789113T AT03789113T ATE553103T1 AT E553103 T1 ATE553103 T1 AT E553103T1 AT 03789113 T AT03789113 T AT 03789113T AT 03789113 T AT03789113 T AT 03789113T AT E553103 T1 ATE553103 T1 AT E553103T1
Authority
AT
Austria
Prior art keywords
pantoprazole
producing
Prior art date
Application number
AT03789113T
Other languages
English (en)
Inventor
Bernhard Kohl
Bernd Mueller
Ralf Steffen Weingart
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE553103T1 publication Critical patent/ATE553103T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
AT03789113T 2002-12-06 2003-12-03 Verfahren zur herstellung von (s)-pantoprazol ATE553103T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027274 2002-12-06
DE10340254 2003-08-29
PCT/EP2003/013604 WO2004052881A2 (en) 2002-12-06 2003-12-03 Process for preparing (s)-pantoprazole

Publications (1)

Publication Number Publication Date
ATE553103T1 true ATE553103T1 (de) 2012-04-15

Family

ID=32509783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03789113T ATE553103T1 (de) 2002-12-06 2003-12-03 Verfahren zur herstellung von (s)-pantoprazol

Country Status (20)

Country Link
US (1) US7301030B2 (de)
EP (1) EP1575941B1 (de)
JP (1) JP2006514985A (de)
KR (1) KR101169471B1 (de)
AR (1) AR042278A1 (de)
AT (1) ATE553103T1 (de)
AU (1) AU2003293749B2 (de)
BR (1) BR0316702A (de)
CA (1) CA2507889C (de)
CY (1) CY1112888T1 (de)
DK (1) DK1575941T3 (de)
ES (1) ES2383679T3 (de)
HK (1) HK1078863A1 (de)
IL (1) IL168554A (de)
MX (1) MXPA05005761A (de)
PL (1) PL375695A1 (de)
PT (1) PT1575941E (de)
SI (1) SI1575941T1 (de)
TW (1) TWI313267B (de)
WO (1) WO2004052881A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
NZ540815A (en) 2002-12-06 2008-03-28 Nycomed Gmbh Process for preparing optically pure active compounds
JP2006514108A (ja) * 2002-12-19 2006-04-27 テバ ファーマシューティカル インダストリーズ リミティド パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
ES2245277T1 (es) * 2003-03-12 2006-01-01 Teva Pharmaceutical Industries Limited Solidos cristalinos y amorfos de pantoprazol y procedimientos para su preparacion.
CA2528993A1 (en) * 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
CA2568652A1 (en) * 2004-06-02 2005-12-15 Altana Pharma Ag Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
US7601737B2 (en) 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
CA2660112A1 (en) * 2006-08-08 2008-02-14 Jubilant Organosys Limited Process for producing sulphoxide compounds
EP2065379A4 (de) 2006-10-13 2011-01-19 Eisai R&D Man Co Ltd Benzimidazolverbindung mit magensäure-sekretion verhindernder aktivität
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2009066321A2 (en) * 2007-10-03 2009-05-28 Ipca Laboratories Limited Process for optically active sulfoxide compounds
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
CN103275064B (zh) * 2012-11-06 2014-08-06 寿光富康制药有限公司 一种埃索美拉唑的制备方法及埃索美拉唑钠的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
SE465514B (sv) 1990-02-19 1991-09-23 Curt Pettersson Foerfarande och anvaendning av ett separationsmedium vid separation av enantiomerer
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
WO1994024867A1 (en) 1993-04-27 1994-11-10 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
AU6713394A (en) 1993-04-27 1994-11-21 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
GB9805558D0 (en) 1998-03-17 1998-05-13 Knoll Ag Chemical process`
NZ540815A (en) 2002-12-06 2008-03-28 Nycomed Gmbh Process for preparing optically pure active compounds

Also Published As

Publication number Publication date
IL168554A (en) 2011-06-30
US7301030B2 (en) 2007-11-27
CA2507889C (en) 2012-02-07
SI1575941T1 (sl) 2012-08-31
KR20050085191A (ko) 2005-08-29
AU2003293749B2 (en) 2009-12-24
EP1575941A2 (de) 2005-09-21
CA2507889A1 (en) 2004-06-24
BR0316702A (pt) 2005-10-18
ES2383679T3 (es) 2012-06-25
TW200510376A (en) 2005-03-16
TWI313267B (en) 2009-08-11
AU2003293749A1 (en) 2004-06-30
WO2004052881A3 (en) 2004-11-04
KR101169471B1 (ko) 2012-07-30
US20060167262A1 (en) 2006-07-27
DK1575941T3 (da) 2012-07-09
PL375695A1 (en) 2005-12-12
AR042278A1 (es) 2005-06-15
WO2004052881A2 (en) 2004-06-24
HK1078863A1 (en) 2006-03-24
EP1575941B1 (de) 2012-04-11
CY1112888T1 (el) 2016-04-13
PT1575941E (pt) 2012-06-19
MXPA05005761A (es) 2005-08-16
JP2006514985A (ja) 2006-05-18

Similar Documents

Publication Publication Date Title
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE340819T1 (de) Verfahren zur herstellung von polyamiden
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
DE60330050D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
ATE296287T1 (de) Verfahren zur herstellung von repaglinide
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE336478T1 (de) Verfahren zur herstellung von benzophenonen
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE471941T1 (de) Verfahren zur herstellung von thiazolopyrimidinen
ATE371642T1 (de) Verfahren zur herstellung von 3- methylthiopropanal
DE60336173D1 (de) Verfahren zur herstellung von vanadylpyrophosphat-katalysatoren
ATE442352T1 (de) Verfahren zur herstellung von modafinil
ATE382621T1 (de) Verfahren zur herstellung von nevirapin
ATE352573T1 (de) Verfahren zur herstellung von copolymerisaten